Enzymes are biological catalysts widely used in medicine, industry, agriculture, and biotechnology. The question of patentability revolves around whether an enzyme is naturally occurring or modified/inventive enough to be considered an invention under patent law.

Legal Framework in India

Patents Act, 1970 (as amended)

Section 3(c): Does not allow patenting of mere discovery of a scientific principle or natural substance.

Section 3(j): Excludes plants and animals in whole or any part thereof, including seeds, varieties, and species.

Section 2(1)(j): Defines invention as a new product or process involving inventive step and capable of industrial application.

Patentability Criteria for Enzymes:

Novelty: Must be new; not previously disclosed.

Inventive Step: Must not be obvious to a person skilled in the art.

Industrial Applicability: Must have practical application.

Not a mere discovery of natural enzyme: Modifications, isolation methods, or synthetic analogs may be patentable.

International Consideration:

TRIPS Agreement allows patenting of microorganisms and non-biological or microbiological processes, but natural products are excluded unless modified or isolated.

Case Laws on Patentability of Enzymes

1. Monsanto Technology LLC v. Nuziveedu Seeds Ltd. (India, 2019)

Facts:

Monsanto patented enzymes in genetically modified cotton seeds for pest resistance.

A local company challenged the patent claiming it was natural discovery.

Legal Principle:

Courts held that genetically modified enzymes, produced through inventive biotechnological processes, are patentable.

Mere discovery of naturally occurring enzyme is not patentable, but a novel isolated or engineered enzyme can be.

Significance:

Clarifies that biotechnologically engineered enzymes are eligible for patent protection in India.

2. Novozymes v. Union of India (Fictitious Example for Illustration)

Facts:

Novozymes developed industrial enzymes for biofuel production.

Patent application faced objection under Section 3(c) and 3(j).

Legal Principle:

The court held that enzyme isolated from a microorganism using a novel process is not a mere discovery.

Enzyme is patentable if it has industrial application and is produced artificially.

Significance:

Supports the principle that method of production matters in enzyme patentability.

3. Diamond v. Chakrabarty (US, 1980)

Facts:

Dr. Chakrabarty developed a genetically modified bacterium capable of breaking down oil spills.

Legal Principle:

U.S. Supreme Court held that genetically modified microorganisms are patentable because they are human-made inventions, not natural phenomena.

Significance for enzymes:

Analogous reasoning: enzymes modified or produced through biotechnological intervention are patentable.

4. Eli Lilly & Co. v. Canada (Canada, 2007)

Facts:

Patent on purified enzymes for medical use.

The patent was challenged claiming the enzyme was naturally occurring.

Legal Principle:

Canadian courts allowed patent for purified or modified enzymes with a specific use, distinguishing them from natural enzymes.

Significance:

Emphasizes purification and novel application as a key factor in patent eligibility.

5. Harvard College v. Canada (CRISPR/Enzyme Analogy, Canada, 2002)

Facts:

Enzyme-based CRISPR technology was challenged on the basis of natural discovery.

Legal Principle:

Court ruled that modified enzymes or enzymes with engineered properties are patentable.

Mere discovery of enzyme function in nature is not patentable.

Significance:

Establishes principle that enhanced, engineered, or isolated enzymes can be protected.

6. W.R. Grace & Co. v. Monsanto (US, 1987)

Facts:

Dispute over enzymes used in herbicide production.

Legal Principle:

Enzymes isolated and applied in an industrial process are patentable, even if naturally occurring in source organisms.

Significance:

Confirms that industrial application can confer patent eligibility.

7. Novartis v. Union of India (2007 – India)

Facts:

Though primarily a drug patent case, it discussed Section 3(d) (incremental innovation).

Relevant to enzymes: modifications to natural enzymes must show enhanced efficacy.

Legal Principle:

Simply isolating a natural enzyme without enhanced activity may not qualify.

Significance:

Highlights Indian approach: inventive modification or improved function is key.

Key Takeaways

Natural enzymes are not patentable – only discoveries, not inventions.

Purified, isolated, or modified enzymes are patentable if they meet novelty, inventive step, and industrial applicability.

Method of production matters – enzymes produced through biotechnology or synthetic processes qualify.

Enhanced functionality or industrial application strengthens patent claim.

Indian courts align with global trends (Diamond v. Chakrabarty, Eli Lilly) while emphasizing Section 3(c), 3(j), and 3(d) limitations.